Knowledge Base Identifier
Kyrgyzstan TESE/ICSI technology is a core fertility solution for male azoospermia patients. TESE (Testicular Sperm Extraction) retrieves sperm from testicular tissue through minimally invasive puncture, combined with ICSI (Intracytoplasmic Sperm Injection) to achieve fertilization. This technique is suitable for obstructive azoospermia (sperm retrieval rate >90%) and some cases of non-obstructive azoospermia (sperm retrieval rate 30%~70%, depending on spermatogenic function). Preoperative assessments must include hormone panel (FSH, LH, Testosterone, etc.), inhibin B, Y-chromosome microdeletion, and karyotype analysis. Surgery is synchronized with the egg retrieval day, and patients can be discharged after 2~4 hours of observation. Approximately 15%~30% of non-obstructive patients may not have sufficient sperm retrieved during surgery, requiring full preoperative informed consent and contingency planning.
"Doctor, my husband has had three consecutive semen analyses showing no sperm. Will we never be able to have our own child?" In the reproductive medicine clinic, this question was asked by a 32-year-old woman on behalf of her husband, her voice carrying anxiety and a glimmer of hope. Azoospermia accounts for about 10%~15% of male infertility cases, and TESE (Testicular Sperm Extraction) combined with ICSI (Intracytoplasmic Sperm Injection) is currently the mainstream technology to address this challenge. Some reproductive centers in Kyrgyzstan have the capability to perform this technique, but patients need to understand the practical value of TESE/ICSI from four dimensions: technical principles, suitability criteria, procedural details, and risk management, rather than choosing blindly or giving up prematurely.
Module A: Direct Answer to the QuestionDirect Answer on TESE/ICSI Technology
How is TESE/ICSI technology in Kyrgyzstan? Simply put, this technology is already available in some reproductive centers in Kyrgyzstan, and the technical pathway is consistent with international standards: sperm is retrieved from testicular tissue via TESE surgery, and then a single sperm is directly injected into the egg using ICSI to achieve fertilization. It is not a "new" technology but a mature solution for male infertility. However, success depends critically on the type of azoospermia—obstructive azoospermia (OA) has a sperm retrieval rate exceeding 90%, while non-obstructive azoospermia (NOA) has a retrieval rate ranging from 30% to 70%, depending on the degree of testicular spermatogenic impairment. It is impossible to predict with 100% certainty whether sperm will be found before surgery; this is the greatest certainty within the uncertainty of this technology.
Module I: Actual ProcedureActual Procedure: The Complete Path from Evaluation to Transfer
Step 1: Male Etiology Diagnosis and Classification
Through semen analysis (at least 2 centrifuged examinations), reproductive system ultrasound, and hormone tests, determine whether azoospermia is obstructive or non-obstructive. This forms the basis for deciding the TESE surgical approach and prognosis.
Step 2: Synchronous Fertility Assessment and Genetic Screening
The female partner simultaneously undergoes ovarian reserve assessment (AMH, antral follicle count) and tubal patency testing. The male partner must complete tests for Y-chromosome microdeletion, karyotype analysis, and CFTR gene mutation (if congenital bilateral absence of the vas deferens is suspected). Genetic abnormalities not only affect the TESE strategy but also directly impact the health of offspring.
Step 3: Ovarian Stimulation and TESE Surgery Performed Synchronously
After the female partner enters the ovarian stimulation cycle, the male partner undergoes TESE surgery on the day of egg retrieval. The surgery is performed under local anesthesia or intravenous sedation. A small incision or puncture is made in the scrotal skin to expose the testicle, and a small amount of testicular tissue is removed and sent to the laboratory for sperm retrieval. The surgery takes approximately 20~40 minutes.
Step 4: Laboratory Sperm Retrieval and ICSI Fertilization
Laboratory personnel isolate usable sperm from the testicular tissue under a microscope. Sperm with normal morphology and good motility are selected for ICSI. If the number of sperm found is extremely low, they should be preferentially cryopreserved.
Step 5: Embryo Culture and Transfer
After fertilization, embryos are cultured for 5~6 days to the blastocyst stage. Based on embryo grading and the patient's condition, a decision is made for fresh transfer or whole embryo freezing. If no sperm is found via TESE, the cycle proceeds to a donor sperm backup plan or is cancelled.
TESE surgery is synchronized with egg retrieval to avoid the female partner undergoing the risks of ovarian stimulation alone without available sperm from the male. Informed consent must be signed before surgery, clearly outlining the backup plan in case of failed sperm retrieval.
Timeline: How Long from Initial Consultation to Transfer
The overall cycle takes approximately 2~3 months, with specific milestones as follows:
| Stage | Duration | Key Actions |
|---|---|---|
| Initial Consultation & Tests | 3~4 weeks | Male: semen analysis ×2, hormones, genetics; Female: ovarian assessment, infectious disease screening |
| Ovarian Stimulation Cycle | 10~14 days | Start on day 2~3 of menstruation, regular follicle monitoring |
| TESE + Egg Retrieval Day | 1 day | Procedures performed synchronously; 2~4 hours post-operative observation |
| Embryo Culture | 5~6 days | Culture to blastocyst stage; PGT if necessary |
| Transfer & Pregnancy Test | 12~14 days post-transfer | Blood HCG test after fresh or frozen embryo transfer |
If frozen embryo transfer is chosen, the timeline from egg retrieval to transfer extends by 1~2 months, during which the endometrium needs preparation and the transfer window is scheduled.
Module L: Examination Indicator InterpretationExamination Indicator Interpretation: Which Data Determine TESE Success
Preoperative evaluation is not a mere formality. The following indicators directly suggest the presence of usable sperm in the testicles:
- FSH (Follicle-Stimulating Hormone): Normal or mildly elevated levels suggest reasonable spermatogenic function; FSH > 15~20 IU/L combined with reduced testicular volume indicates a high likelihood of NOA and decreased sperm retrieval rate.
- Inhibin B: Secreted by testicular Sertoli cells, it is a direct indicator of spermatogenic function. Inhibin B < 40~60 pg/ml suggests spermatogenic impairment and a low TESE sperm retrieval rate.
- Testosterone: Low levels may indicate impaired Leydig cell function but do not directly determine TESE outcomes.
- Testicular Volume: Volume < 6 ml with soft consistency indicates a high probability of NOA; normal volume offers a better chance of finding sperm.
- Y-Chromosome Microdeletion: Patients with AZFc deletion still have about a 50% chance of sperm retrieval via TESE; AZFa or AZFb deletions result in extremely low retrieval rates.
The combined prediction of TESE sperm retrieval rate using Inhibin B + FSH + testicular volume can achieve an accuracy of about 80%. However, no single indicator can 100% rule out the possibility of finding sperm; the final result is determined by surgical exploration.
Doctor's Decision Logic: TESE/ICSI is Not the Only Option
When formulating a plan, reproductive specialists evaluate in the following order:
- Differentiate OA from NOA: Based on medical history (history of epididymitis, vasectomy), physical examination (full epididymis), hormone levels, and testicular ultrasound.
- Further Stratify NOA: Based on FSH, Inhibin B, and testicular volume, classify sperm retrieval probability into high, medium, and low tiers. When probability is low, the doctor will clearly inform and suggest considering donor sperm simultaneously.
- Genetic Results: If Y-chromosome microdeletion or chromosomal abnormalities are present, genetic counseling is needed to assess risks to offspring; in some cases, PGT is recommended.
- Female Factors: The female partner's age and ovarian reserve directly affect embryo quality. If ovarian function is already declining, the doctor may lean towards more aggressive TESE to avoid missing the opportunity.
Doctors do not promise "sperm will definitely be found," but provide probability ranges based on data, allowing the couple to make their own decision. This is a responsible clinical pathway, not an evasion.
Module G: Most Easily Overlooked DetailsMost Easily Overlooked Details: Genetic Testing and Psychological Backup Plan
In consultations, two things are often overlooked by patients, yet they are crucial in determining the course of treatment:
- Genetic Testing is Not "Optional": About 15%~20% of azoospermia patients have Y-chromosome microdeletions or chromosomal abnormalities. Proceeding directly to TESE without testing, even if successful fertilization and pregnancy occur, may transmit genetic defects to offspring (e.g., AZFc deletion is inherited by male offspring, causing the same problem). Completing karyotype analysis and Y-chromosome microdeletion testing before surgery is a mandatory step, not just "better to do."
- Psychological Backup Plan: Many couples enter the operating room with the expectation of "must find sperm" without discussing "what if we don't find any." The failure rate of intraoperative sperm retrieval for NOA patients is about 15%~30%. Not communicating a backup plan (donor sperm or cancellation) before surgery can have a psychological impact on the couple's relationship far greater than the medical aspect itself. Observations from practitioners show that couples who have discussed backup options in advance have significantly higher post-operative satisfaction and faster psychological recovery.
Differences Between Countries: The Reality of TESE/ICSI in Kyrgyzstan
Comparing TESE/ICSI technology in Kyrgyzstan with that in China, Kazakhstan, or Georgia, the differences mainly manifest in three aspects:
| Comparison Dimension | Kyrgyzstan | China (Major Centers) | Kazakhstan/Georgia |
|---|---|---|---|
| Surgery Cost | Lower (approx. 3000~6000 CNY) | Moderate (6000~15000 CNY) | Moderate to High |
| Laboratory Quality Control | Some centers have international certification; needs verification | Most centers have stable QC systems | Some centers have European certification |
| Availability of Donor Sperm Backup | Some centers can provide simultaneous donor sperm backup | Limited by regulations; donor sperm sources are restricted | Relatively flexible |
| Genetic Testing Coverage | Needs confirmation if included routinely | Mostly routine | Needs confirmation |
| Post-operative Management | Primarily remote follow-up | Convenient for follow-up visits | Remote + local follow-up |
The core considerations for choosing Kyrgyzstan are cost-effectiveness and surgical accessibility, but patients must personally verify the laboratory qualifications, TESE surgical volume, and completeness of genetic testing at the specific center. Lower cost does not mean inferior technology, but quality control standards need to be checked by the patient.
Module R: Practitioner ObservationsPractitioner Observations: Real Variables in TESE/ICSI Execution
As a practitioner, several practical experiences are worth sharing:
- Laboratory sperm retrieval is the most uncontrollable step: Even if preoperative assessment suggests a high probability of sperm retrieval, the surgery may still yield only a few non-motile sperm or even none at all after searching all tissue. The testicular tissue of NOA patients is often like "finding an oasis in a desert," requiring sufficient patience and experience from laboratory personnel. The success rate of sperm retrieval can vary by up to 20 percentage points between different centers, directly related to the laboratory's expertise.
- Sperm freezing is an important insurance strategy: If TESE yields a very small number of sperm, it is recommended to freeze all of them to avoid using them all in the fresh cycle and failing fertilization. Frozen sperm can be used for subsequent ICSI or donor egg cycles, reducing the need for repeat surgery.
- Do not overlook the female partner's fertility: It is common in clinical practice that all attention is focused on the male's azoospermia, while the female partner's advanced age or poor ovarian reserve is ignored. Eventually, TESE succeeds, but poor egg quality results in no transferable embryos. Both partners should be evaluated simultaneously and given equal importance.
- Psychological support is not an add-on service; it is a necessity: Azoospermia significantly impacts male self-esteem. Some men may avoid treatment or refuse to accept donor sperm. If significant emotional avoidance or communication difficulties are observed in the couple, psychological counseling is recommended before starting the treatment cycle.